First Eagle Investment Management LLC Grows Stock Holdings in Colgate-Palmolive Company $CL

First Eagle Investment Management LLC raised its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 0.2% in the 3rd quarter, Holdings Channel.com reports. The firm owned 7,889,103 shares of the company’s stock after buying an additional 17,881 shares during the quarter. First Eagle Investment Management LLC’s holdings in Colgate-Palmolive were worth $630,655,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Victory Capital Management Inc. lifted its holdings in shares of Colgate-Palmolive by 8.6% in the 3rd quarter. Victory Capital Management Inc. now owns 2,172,721 shares of the company’s stock valued at $173,687,000 after acquiring an additional 171,434 shares during the last quarter. 111 Capital purchased a new stake in Colgate-Palmolive during the third quarter valued at approximately $460,000. Elo Mutual Pension Insurance Co lifted its stake in shares of Colgate-Palmolive by 33.7% in the 3rd quarter. Elo Mutual Pension Insurance Co now owns 106,068 shares of the company’s stock valued at $8,479,000 after purchasing an additional 26,713 shares during the last quarter. WASHINGTON TRUST Co increased its position in shares of Colgate-Palmolive by 66.7% during the 3rd quarter. WASHINGTON TRUST Co now owns 11,311 shares of the company’s stock valued at $904,000 after purchasing an additional 4,525 shares during the last quarter. Finally, Fisher Asset Management LLC raised its holdings in Colgate-Palmolive by 25.5% during the 3rd quarter. Fisher Asset Management LLC now owns 26,096 shares of the company’s stock valued at $2,086,000 after buying an additional 5,307 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have weighed in on CL shares. Jefferies Financial Group boosted their price objective on shares of Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. JPMorgan Chase & Co. lifted their price target on shares of Colgate-Palmolive from $93.00 to $97.00 and gave the stock an “overweight” rating in a research note on Monday, February 2nd. Rothschild & Co Redburn set a $93.00 price objective on shares of Colgate-Palmolive in a research report on Friday, February 13th. Bank of America raised their price objective on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Finally, UBS Group upped their target price on Colgate-Palmolive from $90.00 to $93.00 and gave the company a “buy” rating in a research note on Wednesday, January 14th. Eleven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average target price of $94.75.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Colgate’s 2030 Strategic Plan and an analyst rating upgrade reinforce the company’s long‑term growth story (brand focus, science‑driven product development and omnichannel execution), which helped shares rally into the plan reveal. Colgate Palmolive (CL) Valuation Check After 2030 Plan Reveal And Analyst Rating Upgrade
• Neutral Sentiment: Market strategists are flagging broader equity risk as the Iran conflict evolves; that raises overall market volatility but consumer staples like Colgate often outperform cyclicals in such environments. Iran escalation compounds AI and credit worries, Barclays’ Cau warns
• Negative Sentiment: Former Treasury Secretary Janet Yellen warned the Iran conflict could slow U.S. growth and push up inflation, reducing the Fed’s room to cut rates — a backdrop that can weigh on valuation multiples for many stocks, including consumer names. Yellen says Iran conflict puts Fed on hold, complicates rate cuts
• Negative Sentiment: Rising oil and gas expectations due to risks around the Strait of Hormuz increase input and transportation cost pressure for packaged‑goods companies, which can compress margins if not passed through to consumers. Oil, gas seen rising as Hormuz risks mount after U.S., Israel-Iran strikes
• Negative Sentiment: Shipping disruptions are intensifying (major Japanese carriers have suspended Persian Gulf operations), raising short‑term supply‑chain and logistics risks that could increase costs or delay inventory flows for multinational consumer firms. Japanese shipping giants pull back as Strait of Hormuz ’practically closes’
• Negative Sentiment: Analysts are repricing energy exposure as geopolitical risk lifts oil risk premia (BofA raised price targets on oil majors), signaling higher fuel and transport costs that can pressure margins for consumer staples. Chevron, Exxon price targets raised at BofA on increased oil risk premium

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, COO Panagiotis Tsourapas sold 15,000 shares of the stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at approximately $1,018,691.15. This trade represents a 59.02% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Sally Massey sold 15,851 shares of Colgate-Palmolive stock in a transaction on Thursday, February 5th. The shares were sold at an average price of $95.03, for a total value of $1,506,320.53. Following the completion of the transaction, the insider owned 13,751 shares in the company, valued at $1,306,757.53. This represents a 53.55% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 184,683 shares of company stock worth $17,486,693 over the last quarter. 0.41% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $97.23 on Tuesday. The firm’s 50 day simple moving average is $87.86 and its 200-day simple moving average is $82.78. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a one year low of $74.54 and a one year high of $100.18. The firm has a market cap of $78.37 billion, a PE ratio of 37.11, a price-to-earnings-growth ratio of 4.47 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.91 by $0.04. The company had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.Colgate-Palmolive’s revenue was up 5.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.91 earnings per share. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, February 13th. Stockholders of record on Wednesday, January 21st were issued a $0.52 dividend. The ex-dividend date was Wednesday, January 21st. This represents a $2.08 annualized dividend and a dividend yield of 2.1%. Colgate-Palmolive’s payout ratio is currently 79.39%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.